by American Society of Hematology Credit: Pixabay/CC0 Public Domain Ask the average American what their blood type is, and you will likely receive a blank look. For most people, blood type only becomes an issue if they need a blood transfusion. Beginning in the earliest days of the COVID-19 pandemic, however, results from previous work published in Blood Advances suggested...
by American College of Physicians Credit: Annals of Internal Medicine (2023). DOI: 10.7326/M22-2381 An analysis of a COVID-19 trial has found that a combination of symptoms and viral rebound after untreated COVID-19 infection is rare, occurring in only 3% of study participants. The analysis is published in Annals of Internal Medicine. Nirmatrelvir–ritonavir is a recommended treatment for outpatients...
By CEDARS-SINAI MEDICAL CENTER JANUARY 10, 2023 Postural Orthostatic Tachycardia Syndrome (POTS) is a disorder that affects the autonomic nervous system and is characterized by an abnormal increase in heart rate upon standing up. This can cause symptoms such as lightheadedness, fainting, fatigue, and headaches. Smidt Heart Institute researchers show the risk of developing postural orthostatic tachycardia syndrome, or...
BOSTON UNIVERSITY SCHOOL OF MEDICINE (Boston)— Recent evidence has emerged to suggest that age-related macular degeneration (AMD) is a clinical risk factor for increased risk for infection and mortality. AMD has been reported to confer higher risk of severe complications of SARS-CoV-2 infection, including respiratory failure and death (25 percent), a risk which is higher than Type 2...
by Lancet Credit: Unsplash/CC0 Public Domain Molnupiravir (taken as an 800mg dose twice daily for five days) does not reduce hospital admissions or deaths in vaccinated adults with COVID-19 infection who are at higher risk of mortality, according to the results of a randomized controlled trial, published in The Lancetjournal. However, the patients treated at home with...
CLEVELAND CLINIC New research findings have revealed an underlying genetic cause for why some children who have had COVID-19 infection develop Multisystem Inflammatory Syndrome in Children (MIS-C), a rare but potentially life-threatening disease. The findings are the first potential genetic cause identified for MIS-C, a disease that typically occurs about four weeks after COVID-19 infection and...
UNIVERSITY OF CAMBRIDGE IMAGE: BILE DUCT/LIVER ORGANOID INFECTED WITH SARS-COV-2 – RED INDICATES THE VIRUS CREDIT: TERESA BREVINI Cambridge scientists have identified an off-patent drug that can be repurposed to prevent COVID-19 – and may be capable of protecting against future variants of the virus – in research involving a unique mix of ‘mini-organs’, donor...
by Houston Methodist The interaction of SARS-CoV-2 with olfactory cilia for entering the central nervous system (CNS). A) Different layers of cells in the nasal cavity that contain receptors for the very first viral entry into the human host. Some of the olfactory cells express ACE2 receptors that endocytose bound viral particles, before their way...
Carla Nieto Martínez May 06, 2022 MADRID, Spain — Clinical experiences in approaching COVID-19 from different perspectives, results obtained by various therapeutic options and, above all, the challenges posed by a new healthcare reality — long COVID — were all the focus of a recent discussion at the 7th International Congress of the Spanish Society of...
The risk for retinal vein occlusion (RVO) may be increased in the six months following COVID-19 infection, according to a study published online April 14 in JAMA Ophthalmology. Bobeck S. Modjtahedi, M.D., from the Southern California Permanente Medical Group in Pasadena, and colleagues conducted a cohort study involving 432,515 patients without a history of retinal vascular occlusion who...
